Abstracts tagged "Health Assessment Questionnaire and rheumatoid arthritis (RA)"

Abstract Number: 2539 • 2016 ACR/ARHP Annual Meeting
Analysis of Joints Susceptible to Rheumatoid Arthritis (RA) and Their Recovery Sequence Based on DAS28 and Physical Function Based on HAQ with Smart System of Disease Management (SSDM) in China：a Prospective Cohort Study
Rong Mu¹, Jing Yang², Hongzhi Wang³, Xinwang Duan⁴, Jianling Dong², Fengxiao Zhang⁵, Wenqiang Fan⁶, Huifang Guo⁷, Tong Xie⁸, Fei Xiao⁹, Hui Xiao⁹, Yuhua Jia⁹, Minjun Wang⁹, Yuan Liu⁹, Bing Wu⁹ and Zhanguo Li¹⁰, ¹Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China, ²Department of rheumatology, Central Hospital of MianYang, Sichuan, Mian Yang, China, ³The First Hospital of Jiaxing, Jiaxing, China, ⁴Department of rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, China, ⁵Department of rheumatology, Hebei General Hospital, Shijiazhuang, China, ⁶Department of rheumatology, Central Hospital of XinXiang, Henan, XinXiang, China, ⁷The Second Hospital of Hebei Medical University, Shijiazhuang, China, ⁸Affiliated hospital of Guangdong medical University, Zhanjiang, China, ⁹Gothic Internet Technology Corporation, Shanghai, China, ¹⁰Peking University People's Hospital, Beijing, China
Background/Purpose: The disease activity score in 28 joints (DAS28) and health assessment questionnaire (HAQ) serve as guides for the treatment of rheumatoid arthritis (RA). Smart…
Abstract Number: 1533 • 2015 ACR/ARHP Annual Meeting
Age Related Disability in Daily Life Should be Considered in Older Than Sixty-Five-Year-Old Rheumatoid Arthritis Patient
Ichiro Yoshii¹ and Tatsumi Chijiwa², ¹Department of Orthopaedic Surgery, Yoshii Hospital, Shimanto, Japan, ²Rheumatology, Kochi Memorial Hospital, Kochi, Japan
Background/Purpose: In treating rheumatoid arthritis (RA), patient’s activity in daily life (ADL) is extremely important factor, because RA is chronic inflammatory disease that leads discomfort…
Abstract Number: 2314 • 2015 ACR/ARHP Annual Meeting
Minimal Important Difference in HAQ: A Validation from Health Economic Perspectives in Patient with Rheumatoid Arthritis Using Real-World Data
Chenglong Han¹, Nan Li² and Steven Peterson³, ¹Outcomes Research, Janssen Global Services, LLC, Malvern, PA, ²Janssen Global Services, LLC, Spring House, PA, ³Janssen Global Services, LLC, Malvern, PA
Background/Purpose: A change of 0.25 in HAQ score has been considered as clinically meaningful. This study is to evaluate the clinical meaningfulness of the HAQ…
Abstract Number: 2738 • 2015 ACR/ARHP Annual Meeting
A Comparison of EQ5D Index from the UK, US, and Japan Preference Weights Model, and Mapping Algorithm from Clinical Outcomes in Patients with Rheumatoid Arthritis: Results from Golimumab Intravenous Study
Chenglong Han¹, Clifton O. Bingham III², Rene Westhovens³, Michael Weinblatt⁴, Lilianne Kim⁵, Daniel Baker⁵, Steven Peterson⁶ and Elizabeth C. Hsia^5,7, ¹Outcomes Research, Janssen Global Services, LLC, Malvern, PA, ²Johns Hopkins University, Baltimore, MD, ³Rheumatology, UZ Gasthuisburg, Leuven, Belgium, ⁴Brigham & Women's Hospital, Boston, MA, ⁵Janssen Research & Development, LLC, Spring House, PA, ⁶Janssen Global Services, LLC, Malvern, PA, ⁷University of Pennsylvania, Philadelphia, PA
Background/Purpose: To compare the EQ5D index from the UK, US, and Japan preference weights models in patients with rheumatoid arthritis (RA), and to examine the…
Abstract Number: 2143 • 2012 ACR/ARHP Annual Meeting
Analysis of Factors Associated with the Health Assessment Questionnaire Score Change in Five Years
Shinji Yoshida¹, Katsunori Ikari², Kensuke Ochi³, Yoshiaki Toyama⁴, Atsuo Taniguchi⁵, Hisashi Yamanaka¹ and Shigeki Momohara¹, ¹Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ²Department of Orthopaedic Surgery, Institute of Rheumatology, Tokyo Women's Medical University, Shinjuku-ku, Japan, ³Department of Orthopaedic Surgery, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ⁴Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan, ⁵Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
Background/Purpose: The Health Assessment Questionnaire (HAQ) score is thought to be a disease specific tool for the assessment of inflammatory joint disorders including rheumatoid arthritis…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].